A company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights
Sept 18 (Reuters) - Pfizer (PFE.N) expects 24% of the U.S. population, or about 82 million people, to receive COVID-19 shots this year, CFO David Denton said at a conference on Monday, reiterating the vaccine maker's estimates from earlier this year.
The U.S. Food and Drug Administration has authorized updated COVID vaccines from Pfizer and its partner BioNTech (22UAy.DE), as well as from Moderna, as the country prepares to start a fall vaccination campaign. A third vaccine from Novavax (NVAX.O) is also under review.
